KEGG   DRUG: TetrabenazineHelp
Entry
D08575                      Drug                                   

Name
Tetrabenazine (JAN/INN);
Nitoman (TN);
Xenazine (TN)
Product
  Generic
Formula
C19H27NO3
Exact mass
317.1991
Mol weight
317.4226
Structure
Mol fileKCF fileDB search
Simcomp SIMCOMP
Class
Enzyme substrate
 DG01892  CYP1A2 substrate
 DG01644  CYP2D6 substrate
Remark
Same as: C11168
Therapeutic category: 1190
ATC code: N07XX06
Product: D08575<JP/US>
Efficacy
Neuroleptic, Vesicular monoamine transporter inhibitor
  Disease
Huntington's disease [DS:H00059]
Target
SLC18A2 (VMAT2) [HSA:6571] [KO:K08155]
  Pathway
hsa04721  Synaptic vesicle cycle
hsa04726  Serotonergic synapse
hsa04728  Dopaminergic synapse
Metabolism
Enzyme: CYP2D6 [HSA:1565]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CBR [HSA:873 874]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N07 OTHER NERVOUS SYSTEM DRUGS
   N07X OTHER NERVOUS SYSTEM DRUGS
    N07XX Other nervous system drugs
     N07XX06 Tetrabenazine
      D08575  Tetrabenazine (JAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Central Nervous System Agents
  Central Nervous System, Other
   Tetrabenazine
    D08575  Tetrabenazine (JAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   119  Miscellaneous
    1190  Miscellaneous
     D08575  Tetrabenazine (JAN/INN)
Target-based classification of drugs [BR:br08310]
 Transporters
  Solute carrier family
   SLC18
    SLC18A2 (VMAT2)
     D08575  Tetrabenazine (JAN/INN) <JP/US>
Drug classes of therapeutic agents [br08360.html]
 Neurological agents
  D08575
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D08575
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D08575
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D08575
Pharmacogenomic biomarkers [br08341.html]
 Polymorphisms and germline mutations
  D08575
BRITE hierarchy
Other DBs
CAS: 58-46-8
PubChem: 96025259
ChEBI: 64028 9467
ChEMBL: CHEMBL117785
DrugBank: DB04844
LigandBox: D08575
NIKKAJI: J4.592F
LinkDB All DBs
KCF data Show

ATOM        23
            1   C1x C    24.2200  -16.8700
            2   C1y C    24.2200  -18.2700
            3   N1y N    25.4100  -18.9700
            4   C1x C    26.6700  -18.2700
            5   C1y C    26.6700  -16.8700
            6   C5x C    25.4100  -16.1700
            7   C8y C    23.0300  -18.9700
            8   C8y C    23.0300  -20.3700
            9   C1x C    24.2200  -21.0700
            10  C1x C    25.4100  -20.3700
            11  C8y C    20.5800  -18.9700
            12  C8y C    20.5800  -20.3700
            13  C8x C    21.7700  -21.0700
            14  C8x C    21.7700  -18.2700
            15  O5x O    25.4100  -14.7700
            16  C1b C    27.8600  -16.1700
            17  C1c C    29.0500  -16.8700
            18  C1a C    30.2400  -16.1700
            19  C1a C    29.0500  -18.2700
            20  O2a O    19.3900  -18.2700
            21  O2a O    19.3900  -21.0700
            22  C1a C    18.1300  -18.9700
            23  C1a C    18.1300  -20.3700
BOND        25
            1     5   6 1
            2     6   1 1
            3    11  12 2
            4    12  13 1
            5    13   8 2
            6     7  14 2
            7    14  11 1
            8     1   2 1
            9     6  15 2
            10    2   3 1
            11    5  16 1
            12    3   4 1
            13   16  17 1
            14    7   8 1
            15   17  18 1
            16    8   9 1
            17   17  19 1
            18    9  10 1
            19   11  20 1
            20   10   3 1
            21   12  21 1
            22    2   7 1
            23   20  22 1
            24    4   5 1
            25   21  23 1

» Japanese version   » Back

DBGET integrated database retrieval system